C B Deery1, C F Hanrahan2, K Selibas1, J Bassett3, I Sanne1, A Van Rie2. 1. Clinical HIV Research Unit, Department of Medicine, University of the Witwatersrand, Johannesburg, South Africa. 2. University of North Carolina Gillings School of Global Public Health, Chapel Hill, North Carolina, USA. 3. Witkoppen Health and Welfare Center, Johannesburg, South Africa.
Abstract
SETTING: Primary care clinic serving a high tuberculosis (TB) and human immunodeficiency virus (HIV) prevalence community in South Africa. OBJECTIVE: To evaluate a program combining TB and HIV contact investigation with tracing of individuals lost to TB or HIV care. DESIGN: Contacts were offered home-based HIV testing, TB symptom screening, sputum collection and referral for isoniazid preventive therapy (IPT). Effectiveness was assessed by the number needed to trace (NNT). RESULTS: Only 419/1197 (35.0%) households were successfully traced. Among 267 contacts, we diagnosed 27 new HIV cases (10 linked to care) and two TB cases (both initiated treatment) and three started IPT. Of 630 patients lost to care, 132 (21.0%) were successfully traced and 81 (61.4%) re-engaged in care. The NNT to locate one individual lost to care was 4.8 (95%CI 4.1-5.6), to re-engage one person in care 7.8 (95%CI 6.4-9.7), to diagnose one contact with HIV 44.3 (95%CI 30.6-67.0), to link one newly diagnosed contact to HIV care 120 (95%CI 65.3-249.2) and to find one contact with active TB and initiate treatment 599 (95%CI 166.0-4940.7). CONCLUSION: The effectiveness of this contact tracing approach in identifying new TB and HIV cases was low. Methods to optimize contact investigation should be explored and their cost-effectiveness assessed.
SETTING: Primary care clinic serving a high tuberculosis (TB) and human immunodeficiency virus (HIV) prevalence community in South Africa. OBJECTIVE: To evaluate a program combining TB and HIV contact investigation with tracing of individuals lost to TB or HIV care. DESIGN: Contacts were offered home-based HIV testing, TB symptom screening, sputum collection and referral for isoniazid preventive therapy (IPT). Effectiveness was assessed by the number needed to trace (NNT). RESULTS: Only 419/1197 (35.0%) households were successfully traced. Among 267 contacts, we diagnosed 27 new HIV cases (10 linked to care) and two TB cases (both initiated treatment) and three started IPT. Of 630 patients lost to care, 132 (21.0%) were successfully traced and 81 (61.4%) re-engaged in care. The NNT to locate one individual lost to care was 4.8 (95%CI 4.1-5.6), to re-engage one person in care 7.8 (95%CI 6.4-9.7), to diagnose one contact with HIV 44.3 (95%CI 30.6-67.0), to link one newly diagnosed contact to HIV care 120 (95%CI 65.3-249.2) and to find one contact with active TB and initiate treatment 599 (95%CI 166.0-4940.7). CONCLUSION: The effectiveness of this contact tracing approach in identifying new TB and HIV cases was low. Methods to optimize contact investigation should be explored and their cost-effectiveness assessed.
Authors: Robin Wood; Keren Middelkoop; Landon Myer; Alison D Grant; Andrew Whitelaw; Stephen D Lawn; Gilla Kaplan; Robin Huebner; James McIntyre; Linda-Gail Bekker Journal: Am J Respir Crit Care Med Date: 2006-09-14 Impact factor: 21.405
Authors: Adrienne E Shapiro; Ebrahim Variava; Modiehi H Rakgokong; Neshen Moodley; Binnu Luke; Saeed Salimi; Richard E Chaisson; Jonathan E Golub; Neil A Martinson Journal: Am J Respir Crit Care Med Date: 2012-03-15 Impact factor: 21.405
Authors: K Lönnroth; E Corbett; J Golub; P Godfrey-Faussett; M Uplekar; D Weil; M Raviglione Journal: Int J Tuberc Lung Dis Date: 2013-03 Impact factor: 2.373
Authors: Warren Dalal; Daniel R Feikin; Manase Amolloh; Ray Ransom; Heather Burke; Fillet Lugalia; Alice Ouma; Kayla F Laserson; Jonathan Mermin; Robert F Breiman; Rebecca Bunnell Journal: J Acquir Immune Defic Syndr Date: 2013-02-01 Impact factor: 3.731
Authors: Helen Ayles; Albertus Schaap; Amos Nota; Charalambos Sismanidis; Ruth Tembwe; Petra De Haas; Monde Muyoyeta; Nulda Beyers Journal: PLoS One Date: 2009-05-19 Impact factor: 3.240
Authors: M Armstrong-Hough; J Ggita; P Turimumahoro; A J Meyer; E Ochom; D Dowdy; A Cattamanchi; A Katamba; J L Davis Journal: Int J Tuberc Lung Dis Date: 2018-10-01 Impact factor: 2.373
Authors: Andrew Medina-Marino; Lindsey de Vos; Dana Bezuidenhout; Claudia M Denkinger; Samuel G Schumacher; Sanghyuk S Shin; Wendy Stevens; Grant Theron; Martie van der Walt; Joseph Daniels Journal: Trop Med Int Health Date: 2021-01-04 Impact factor: 2.622
Authors: Nicholas W Albaugh; Bareng A S Nonyane; Lesego Mmolawa; Tsundzukani Siwelana; Limakatso Lebina; David W Dowdy; Neil Martinson; Colleen F Hanrahan Journal: J Acquir Immune Defic Syndr Date: 2020-12-15 Impact factor: 3.731
Authors: Amrita N Shamanewadi; Poonam R Naik; Pruthu Thekkur; Suwarna Madhukumar; Abhay Subhashrao Nirgude; M B Pavithra; Basavaraj Poojar; Vivek Sharma; Arnav Prashanth Urs; B V Nisarga; N Shakila; Sharath Burugina Nagaraja Journal: Tuberc Res Treat Date: 2020-01-24